Epzicom FDA Approval History
Epzicom (abacavir and lamivudine) is a combination of two nucleoside reverse transcriptase inhibitors (NRTIs) indicated for use with other antiretroviral drugs for the treatment of HIV-1 infection in adults.
Development Timeline for Epzicom
|Aug 2, 2004||Approval Epzicom GlaxoSmithKline - Treatment for HIV Infection|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.